Stewart McCallum Net Worth & Insider Trades
Stewart McCallum - Chief Medical Officer, Recro Pharma, Inc
What is Stewart McCallum's Net Worth?
The current estimated net worth of Recro Pharma, Inc's Chief Medical Officer, Stewart McCallum, is estimated to be about $0 . Stewart McCallum owns about 1,250 units of Recro Pharma, Inc common stock. In the last 3 years at Recro Pharma, Inc, Stewart McCallum has sold an estimated value of $58.56K worth.
What is Stewart McCallum's Past Insider Trading?
Stewart McCallum's largest purchase order was 1,250 units , worth over $10.28K on May 31, 2016. In total, Stewart McCallum has made about 6 transactions over 3 years of their time at Recro Pharma, Inc. Stewart McCallum usually trades in January, with the busiest year in 2017 and 2018.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Stewart McCallum
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Stewart McCallum's' Mailing Address?
- Mailing address is C/o Recro Pharma, Inc. 490 Lapp Road Malvern PA 19355 PA
Recro Pharma, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| J. David Enloe, Jr. | 2020 | $10,577 | - | $660,001 | $400,544 | - | $1,678 | $1,072,800 |
| Ryan D. Lake | 2020 | $198,985 | $48,000 | $1,058,040 | $744,327 | $107,640 | $24,673 | $2,181,665 |
| Ryan D. Lake | 2019 | $319,777 | $69,440 | $623,276 | $334,200 | $138,880 | $44,038 | $1,529,611 |
| Gerri Henwood | 2020 | $308,654 | $111,240 | - | - | - | $21,166 | $441,060 |
| Gerri Henwood | 2019 | $553,846 | - | $2,608,537 | $1,062,199 | $360,000 | $38,402 | $4,622,984 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1588972/000156459021015283/reph-def14a_20210420.htm
What are Recro Pharma, Inc's Past Insider Trades?
Recro Pharma, Inc's most recent insider trade came on March 17, 2022 by David Enloe Jr who bought 512 units worth $1K . In the last 8 years, insiders at Recro Pharma, Inc have sold an estimated value of $26.27M and bought an estimated value of $15.87M worth of shares. Insider trading is most common in December, with the busiest year in 2017. The most active traders at the company are Ryan D. Lake, Chief Financial Officer, Geraldine Henwood, Director, and Scp Vitalife Partners Ii Lp .
Recro Pharma, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||